Cerebrovascular Events in 21105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin.

MLA

Giugliano, Robert P., et al. “Cerebrovascular Events in 21105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin.” Stroke (00392499), vol. 45, no. 8, Aug. 2014, pp. 2372–78. EBSCOhost, https://doi.org/10.1161/STROKEAHA.114.006025.

APA

Giugliano, R. P., Ruff, C. T., Rost, N. S., Silverman, S., Wiviott, S. D., Lowe, C., Deenadayalu, N., Murphy, S. A., Grip, L. T., Betcher, J. M., Duggal, A., Dave, J., Minggao Shi, Mercuri, M., Antman, E. M., & Braunwald, E. (2014). Cerebrovascular Events in 21105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin. Stroke (00392499), 45(8), 2372–2378. https://doi.org/10.1161/STROKEAHA.114.006025

Chicago

Giugliano, Robert P., Christian T. Ruff, Natalia S. Rost, Scott Silverman, Stephen D. Wiviott, Cheryl Lowe, Naveen Deenadayalu, et al. 2014. “Cerebrovascular Events in 21105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin.” Stroke (00392499) 45 (8): 2372–78. doi:10.1161/STROKEAHA.114.006025.